5-Hydroxytryptamine (5-HT3) receptor antagonists. 2. 1-Indolinecarboxamides

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Pharmacology

Background:

• Indazole derivatives have demonstrated significant potential as selective serotonin 5-HT3 receptor antagonists.
• The 5-HT3 receptor is a validated target for various therapeutic applications, including antiemetics and treatments for irritable bowel syndrome.

Purpose of the Study:

• To synthesize and evaluate a novel series of 1-indolinecarboxamides and 1-indolecarboxamides as potent 5-HT3 receptor antagonists.
• To explore the structural requirements for 5-HT3 receptor antagonist activity, specifically investigating the role of aromaticity in the five-membered ring.

Main Methods:

• Synthesis of a library of 1-indolinecarboxamide (2a-q) and 1-indolecarboxamide (3b,i,j,k) compounds.
• Biological evaluation of synthesized compounds for 5-HT3 receptor antagonist activity.
• Design and synthesis of an indene derivative (9) based on structure-activity relationship hypotheses.

Main Results:

• A novel series of potent 5-HT3 receptor antagonists, including 1-indolinecarboxamides and 1-indolecarboxamides, were identified.
• The activity of the indoline derivatives indicated that aromaticity of the five-membered ring is not crucial for potency.
• The indene derivative (9), designed to maintain a favorable carbonyl group orientation, also exhibited potent 5-HT3 receptor antagonist activity.

Conclusions:

• The study successfully identified novel and potent 5-HT3 receptor antagonists based on indoline and indole scaffolds.
• Findings suggest that maintaining an 'in plane' orientation of the carbonyl group is critical for activity, irrespective of ring aromaticity.
• The developed compounds represent promising leads for further investigation and potential therapeutic development targeting the 5-HT3 receptor.